Premium
Calpain‐mediated androgen receptor breakdown in apoptotic prostate cancer cells
Author(s) -
Yang Huanjie,
Murthy Shalini,
Sarkar Fazlul H.,
Sheng Shijie,
Reddy G. PremVeer,
Dou Q. Ping
Publication year - 2008
Publication title -
journal of cellular physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.529
H-Index - 174
eISSN - 1097-4652
pISSN - 0021-9541
DOI - 10.1002/jcp.21565
Subject(s) - prostate cancer , lncap , celastrol , calpain , cancer research , apoptosis , proteasome , androgen receptor , proteasome inhibitor , programmed cell death , cancer cell , chemistry , prostate , cancer , endocrinology , biology , medicine , microbiology and biotechnology , biochemistry , enzyme
Since androgen receptor (AR) plays an important role in prostate cancer development and progression, androgen‐ablation has been the frontline therapy for treatment of advanced prostate cancer even though it is rarely curative. A curative strategy should involve functional and structural elimination of AR from prostate cancer cells. We have previously reported that apoptosis induced by medicinal proteasome‐inhibitory compound celastrol is associated with a decrease in AR protein levels. However celastrol‐stimulated events contributing to this AR decrease have not been elucidated. Here, we report that a variety of chemotherapeutic agents, including proteasome inhibitors, a topoisomerase inhibitor, DNA‐damaging agents and docetaxel that cause cell death, decrease AR levels in LNCaP prostate cancer cells. This decrease in AR protein levels was not due to the suppression of AR mRNA expression in these cells. We observed that a proteolytic activity residing in cytosol of prostate cancer cells is responsible for AR breakdown and that this proteolytic activity was stimulated upon induction of apoptosis. Interestingly, proteasome inhibitor celastrol‐ and chemotherapeutic drug VP‐16‐stimulated AR breakdown was attenuated by calpain inhibitors calpastatin and N ‐acetyl‐ L ‐leucyl‐ L ‐leucyl‐ L ‐methioninal. Furthermore, AR proteolytic activity pulled down by calmodulin‐agarose beads from celastrol‐treated PC‐3 cells showed immunoreactivity to a calpain antibody. Taken together, these results demonstrate calpain involvement in proteasome inhibitor‐induced AR breakdown, and suggest that AR degradation is intrinsic to the induction of apoptosis in prostate cancer cells. J. Cell. Physiol. 217: 569–576, 2008. © 2008 Wiley‐Liss, Inc.